Cost-Effectiveness Analysis of Sex-Stratified Plasmodium vivax Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure
Tafenoquine has been licensed for the single-dose radical cure of Plasmodium vivax in adults; however, it is only recommended in patients with > 70% of normal glucose-6-phosphate dehydrogenase (G6PD) activity. Because this may hinder widespread use, we investigated sex-based treatment strategies...
Saved in:
Main Authors: | Angela Devine, Rosalind E. Howes, David J. Price, Kerryn A. Moore, Benedikt Ley, Julie A. Simpson, Sabine Dittrich, Ric N. Price |
---|---|
Other Authors: | Melbourne School of Population and Global Health |
Format: | Article |
Published: |
2020
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/57960 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Implementing radical cure diagnostics for malaria: user perspectives on G6PD testing in Bangladesh
by: Nora Engel, et al.
Published: (2022) -
Single-dose radical cure of Plasmodium vivax: A step closer
by: Ric N. Price, et al.
Published: (2018) -
Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
by: Poespoprodjo, Jeanne Rini, et al.
Published: (2022) -
Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure
by: Kamala Thriemer, et al.
Published: (2022) -
Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
by: Jeanne Rini Poespoprodjo, et al.
Published: (2022)